Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout

NCT05253833 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout
Arthritis, Gouty
Hyperuricemia
Gout Chronic

Interventions

DRUG: AR882 Dose 1
DRUG: AR882 Dose 2
DRUG: Allopurinol Tablet

Sponsor

Arthrosi Therapeutics